Press Releases

[May 2005] "PolyTherics (UK) & Shantha Biotechnics (India) sign biotech deal"

PolyTherics, a spin-out company from Imperial College London and the London School of Pharmacy announced, at the Bangalore Bio meeting, that they have agreed to a licensing deal to jointly develop new medicines.

[Apr 2005] "BangaloreBio kicks off with three deals"

(...) Shanta Biotech's pact with PolyTherics, a University of London biotech spin-off, involves a technology transfer agreement which will enable Shantha Biotech to licence PolyTherics's novel pegylation technology to make an affordable PEG-interferon product for the treatment of Hepatitis C.

[Apr 2005] "Go global, come to the UK: British High Commissioner tells India's leading biotech companies"

(...) Other highlights of Sir Michael's speech include: "The technology transfer agreement between Shantha Biotechnics and PolyTherics Ltd is a shining example of how exciting innovations in our best universities can be rapidly turned into new and useful global healthcare products."